Study of 962 patients indicates progressive muscular atrophy is a form of ALS

Neurology

Volumn 74, Issue 23, 2010, Pages 1926-

  Ikeda, Ken ^a   Iwasaki, Yasuo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; LEUKOCYTE ANTIGEN; PROTEIN TDP-43; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; DISEASE COURSE; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MOTONEURON; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; FEMALE; GENETICS; MALE; METABOLISM; NOTE; PATHOLOGY; SPINAL MUSCULAR ATROPHY;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL;

EID: 77953349644     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e03ac0     Document Type: Letter

References (4)

1. Kim W-K, Liu X, Sandner J, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009;73:1686-1692.
2. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis of familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 1997;48:55-57.
3. Takazawa T, Ikeda K, Hirayama T, et al. Familial amyo-trophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease. Intern Med 2010;49:183-186.
4. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.